Intellectual Property India Publishes Patent Application for 'Microbial Consortia' Filed by Kanvas Biosciences, Inc.

MUMBAI, India, Nov. 21 -- Intellectual Property India has published a patent application (202517097812 A) filed by Kanvas Biosciences, Inc., Monmouth Junction, U.S.A., on Oct. 10, for 'microbial consortia.'

Inventor(s) include Swem, Robert, Lee; Hamilton, Joshua, J.; Berleman, James; Jacoby, Kyle; Ciglar, Ariana, M.; Parmar, Anupreet; Bhalla, Aditya; and Kumar, Pawan.

The application for the patent was published on Nov. 21, under issue no. 47/2025.

According to the abstract released by the Intellectual Property India: "The present disclosure provides microbial consortia, and methods of making and using the same, comprising a complete microbiome replacement capable of stable engraftment in the gastrointestinal tract for the treatment of IBD, ulcerative colitis, and Crohn's disease."

The patent application was internationally filed on Mar. 11, 2024, under International application No.PCT/US2024/019341.

Disclaimer: Curated by HT Syndication.